Innovative Monitoring Alio's SmartPatch offers a non-invasive, multi-metric monitoring solution that can significantly reduce the need for blood draws in clinical settings, creating opportunities to position it as a safer and more comfortable alternative for healthcare providers and patients.

Expanding Metrics With planned additional metrics and features, Alio presents ongoing upsell opportunities to existing clients seeking more comprehensive remote monitoring capabilities, especially in chronic care management.

Regulatory Advantage The FDA clearance of Alio's platform enhances its credibility and appeal to healthcare providers and institutions looking for reliable, approved medical devices, facilitating easier entry and broader adoption in clinical environments.

Market Focus Targeting hemodialysis and chronic disease markets where continuous, non-invasive monitoring is highly valued opens doors to partnerships with dialysis centers, hospitals, and specialty clinics seeking innovative care solutions.

Funding & Growth With recent funding of 18M and a revenue estimate between 1M and 10M, Alio is positioned to scale its sales efforts, focusing on expanding its customer base within the rapidly growing wearable medical device segment.